SUPPLEMENTARY MATERIALS
) were plated onto Matrigel-coated 8-μm transwell filters without (0) or with 10 or 50 mg/ml PG545. Invading cells adhering to the lower side of the membrane were visualized (upper panels) and counted (lower panels) after 16 h. (C) Tumor metastasis. LLC were injected to the tail vein of C57Bl/6 mice untreated (Con) or treated with PG545 30 min prior to cell inoculation. Lungs were harvested 30 days later, and examined for lung metastases by gross inspection (upper panel) and by histology (second panels). *denotes lung metastasis. (D, E) Immunoblotting. A549 (D) and HTB-182 (E) human lung carcinoma cells (2 × 10 6 ) were left untreated (0) or treated (16 h) with the indicated concentrations PG545 and cell lysates were subjected to immunoblotting applying anti-phospho-Akt (pAkt; upper panels), anti-Akt (second panels), and anti-actin (lower panels) antibodies. Note decreased Akt phosphorylation in response to PG545. Bar graphs (D, right; E, bottom) denote densitometric analysis of pAkt relative to total Akt.
